title: Interrelationship between activation of matrix metalloproteinases and mitochondrial dysfunction in the development of diabetic retinopathy.
abstract: Mitochondria dysfunction plays a significant role in the apoptosis of retinal cells. Diabetes activates retinal matrix metalloproteinases (MMP-9 and MMP-2), damages retinal mitochondria and activates the apoptotic machinery. This study is to investigate the temporal relationship between the activation of retinal MMPs and mitochondria damage in the development of diabetic retinopathy. Time course of activation of cytosolic MMP-9 and MMP-2 was investigated in the retinal endothelial cells incubated in high glucose for 6-96 h, and correlated with their mitochondrial accumulation and mitochondrial damage. This was confirmed in the retina from rats diabetic for 15 days to ~12 months (streptozotocin-induced). The results show that the activation of cytosolic MMP-9 and MMP-2 is an early event, which is followed by their accumulation in the mitochondria. Increased mitochondrial MMPs dysfunction them and begin to damage their DNA, which initiates a vicious cycle of reactive oxygen species. Thus, modulation of these gelatinase MMPs by pharmacological agents during the early stages of diabetes could provide a strategy to inhibit the development of diabetic retinopathy.
authors.affiliation: Kresge Eye Institute, Wayne State University, Detroit, MI 48201, United States.
authors.forename: Julia M
authors.initials: JM
authors.lastname: Santos
authors.forename: Shikha
authors.initials: S
authors.lastname: Tewari
authors.forename: Jonathan Y
authors.initials: JY
authors.lastname: Lin
authors.forename: Renu A
authors.initials: RA
authors.lastname: Kowluru
mesh_terms: D000818:Animals; D017209:Apoptosis; D002417:Cattle; D002478:Cells, Cultured; D003930:Diabetic Retinopathy / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology*; D004789:Enzyme Activation; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism*; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism*; D008928:Mitochondria / Q000201:enzymology / Q000378:metabolism / Q000473:pathology*; D051381:Rats; D017208:Rats, Wistar; D017382:Reactive Oxygen Species / Q000378:metabolism; D012160:Retina / Q000201:enzymology / Q000378:metabolism / Q000473:pathology*
chemical_list: D017382:Reactive Oxygen Species; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9
keywords: Diabetes; Matrix metalloproteinase; Mitochondria; Retinopathy
references.citation: Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4320-6
references.pmid: 20220057
references.citation: Expert Opin Investig Drugs. 2012 Jun;21(6):797-805
references.pmid: 22519597
references.citation: Nat Rev Neurosci. 2012 Nov;13(11):743-57
references.pmid: 23047773
references.citation: J Cell Physiol. 2012 Mar;227(3):1052-61
references.pmid: 21567393
references.citation: Invest Ophthalmol Vis Sci. 2011 Jun 01;52(6):3832-41
references.pmid: 21345984
references.citation: Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5327-34
references.pmid: 14638734
references.citation: Free Radic Biol Med. 2012 Nov 1;53(9):1729-37
references.pmid: 22982046
references.citation: Int J Cancer. 2006 Oct 15;119(8):1767-75
references.pmid: 16721810
references.citation: Curr Pharm Biotechnol. 2011 Mar 1;12(3):352-61
references.pmid: 20939803
references.citation: J Endocrinol Invest. 2010 May;33(5):292-6
references.pmid: 19820293
references.citation: Antioxid Redox Signal. 2012 Aug 1;17(3):492-504
references.pmid: 22229649
references.citation: Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1581-87
references.pmid: 16356121
references.citation: Free Radic Res. 2003 Nov;37(11):1169-80
references.pmid: 14703729
references.citation: Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3972-8
references.pmid: 11053301
references.citation: Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H890-7
references.pmid: 18567713
references.citation: Expert Opin Ther Targets. 2011 Apr;15(4):357-64
references.pmid: 21254925
references.citation: Amino Acids. 2011 Jul;41(2):271-90
references.pmid: 20640864
references.citation: Invest Ophthalmol Vis Sci. 1999 Mar;40(3):809-13
references.pmid: 10067990
references.citation: Heart Fail Rev. 2003 Jan;8(1):23-8
references.pmid: 12652156
references.citation: J Clin Invest. 1996 Jun 15;97(12):2883-90
references.pmid: 8675702
references.citation: Free Radic Biol Med. 1997;22(4):587-92
references.pmid: 9013121
references.citation: Onkologie. 2013;36(5):256-9
references.pmid: 23689219
references.citation: Diabetes. 2011 Nov;60(11):3023-33
references.pmid: 21933988
references.citation: Crit Rev Biochem Mol Biol. 2010 Oct;45(5):351-423
references.pmid: 20812779
references.citation: Diabetes. 2013 Jul;62(7):2559-68
references.pmid: 23423566
references.citation: Lab Invest. 2010 Sep;90(9):1365-72
references.pmid: 20479714
references.citation: Lancet Neurol. 2009 Feb;8(2):205-16
references.pmid: 19161911